iWOW draws Dr. Lim Cheok Peng, top fund managers in S$15M placement

What's the deal? Singapore's iWOW Technology has completed a S$15 million share placement, issuing 66,667,000 new shares at S$0.225 each to a group of institutional and strategic investors. The post-IPO equity raise expands its issued share capital by 23%, from 287,057,025 to 353,724,025 shares.

Who's in? The register now includes fund managers under Singapore's Equity Market Development Programme and healthcare veteran Dr. Lim Cheok Peng, the cardiologist and former IHH HealthcareDealroom has a profile for this one. Try Dealroom → managing director who led that group's 2012 dual listing.

Other participants include Amova Asset ManagementDealroom has a profile for this one. Try Dealroom →, Areca CapitalDealroom has a profile for this one. Try Dealroom →, Asdew Acquisitions, Avanda Investment ManagementDealroom has a profile for this one. Try Dealroom →, Azure CapitalDealroom has a profile for this one. Try Dealroom →, Ginko-AGT Global Growth Fund, ICH Synergrowth Fund, Lion Global Investors, Tokio Marine Life Insurance Singapore, UOB Asset Management, and Value Partners Hong Kong.

Why now? The fresh capital strengthens iWOW's balance sheet and can support new projects and strategic initiatives, the company said. The new shares are expected to begin trading on the Catalist of the SGX-ST from 9:00 on July 30, 2026.

What could go wrong? Existing shareholders face a 23% dilution from the larger share base. The company frames the offset as sharper market confidence and improved trading liquidity from a wider float.

The signal: The placement's draw is less the sum than the names behind it. Pulling in EQDP-linked fund managers and a healthcare heavyweight signals institutional appetite for the SGX-listed firm — and hints at business relationships iWOW may look to build on.

Read more: minichart.com.sg

Image credit: Generated with Gemini